๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Expression of fascin in thyroid neoplasms: a novel diagnostic marker

โœ Scribed by Guang Chen; Fa-Ren Zhang; Jiang Ren; Li-Hua Tao; Zhong-Ying Shen; Zhuo Lv; Shi-Jiang Yu; Bing-Fei Dong; Li-Yan Xu; En-Min Li

Publisher
Springer-Verlag
Year
2008
Tongue
English
Weight
327 KB
Volume
134
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Expression of galectin-3 in fine-needle
Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms
โœ Hidenori Inohara; Yuichiro Honjo; Tadashi Yoshii; Shiro Akahani; Jun-ichi Yoshid ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 724 KB

## BACKGROUND. Galectin-3 is a โค-galactoside-binding protein that has been reported to be expressed preferentially in thyroid malignancies. The current study was designed to substantiate this finding further and to establish a presurgical diagnostic modality of differentiating between benign and ma

Expression of CD95 ligand in melanocytic
Expression of CD95 ligand in melanocytic lesions as a diagnostic marker
โœ Maeda; Aragane; Tezuka ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 621 KB

CD95 ligand (CD95L) potently induces apoptosis by activating CD95 on target cells. It has recently been reported that melanoma cells in vivo express a significant amount of CD95L, thereby being immediately able to kill CD95-bearing immunocompetent cells specific for cancer antigens, which infiltrate

Diagnostic value of galectin-3 as a mark
Diagnostic value of galectin-3 as a marker for malignancy in follicular patterned thyroid lesions
โœ Yael Oestreicher-Kedem; Marisa Halpern; Pepi Roizman; Britta Hardy; Jaqueline Su ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 609 KB

## Abstract ## Background. The determination of malignancy in follicular patterned thyroid lesions is based on postoperative histologic findings. Therefore, affected patients are referred for surgery, although only 20% will have a final diagnosis of malignancy. The aim of this study was to investi

CD34 expression as a novel marker of tra
CD34 expression as a novel marker of transformed mesangial cells in biopsied glomerular diseases
โœ Naruse, Keishi; Fujieda, Mikiya; Miyazaki, Eriko; Hayashi, Yoshihiro; Kuroda, Na ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 581 KB

CD34 is a marker of haematopoietic progenitor cells, stromal precursors, vascular endothelial cells, and a variety of stromal tumour cells. This immunohistochemical study examined the CD34 expression of glomerular mesangial cells in normal and diseased glomeruli and compared it with the staining pat